SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Boyce Burge who wrote (36)2/12/1997 8:52:00 PM
From: scaram(o)uche   of 4474
 
My guess is that it's both excitement over a gene-regulation deal, and something related to this............

Medline ID:
96185499
Citation:
Taunton J, Hassig CA, Schreiber SL, A mammalian histone
deacetylase related to the yeast transcriptional regulator
Rpd3p [see comments], Science 272: 5260, 408-11, Apr
19, 1996.
Address:
Howard Hughes Medical Institute
Harvard University
Cambridge
MA 02138
USA.
Abstract
Trapoxin is a microbially derived cyclotetrapeptide that inhibits histone deacetylation in vivo
and causes mammalian cells to arrest in the cell cycle. A trapoxin affinity matrix was used
to isolate two nuclear proteins that copurified with histone deacetylase activity. Both
proteins were identified by peptide microsequencing, and a complementary DNA encoding
the histone deacetylase catalytic subunit (HD1) was cloned from a human Jurkat T cell
library. As the predicted protein is very similar to the yeast transcriptional regulator Rpd3p,
these results support a role for histone deacetylase as a key regulator of eukaryotic
transcription.
*********************************************************
wild guess, no rumor, no fact...........

Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext